Finanical Statements
Cairo Pharmaceuticals (CPCI.CA) Reports 3 Months Results
Published at 16 November 2026 at 12:38 Cairo timeCairo PharmaceuticalsRelated stock:Cairo Pharmaceuticals stockAll Cairo Pharmaceuticals disclosures
Disclosure summary
Company Name : Cairo Pharmaceuticals
ISIN Code: EGS38391C016
Currency: EGP
F/S Period: From 01/07/2026 To 30/09/2026
Net Profit: 132,595,847
F/S Period: From 01/07/2025 To 30/09/2025
Net Comparative Profit : 143,676,308
Audit Status : Reviewed
Source : Cairo Pharmaceuticals
The Financial Statements (13,538 KB)
ISIN Code: EGS38391C016
Currency: EGP
F/S Period: From 01/07/2026 To 30/09/2026
Net Profit: 132,595,847
F/S Period: From 01/07/2025 To 30/09/2025
Net Comparative Profit : 143,676,308
Audit Status : Reviewed
Source : Cairo Pharmaceuticals
The Financial Statements (13,538 KB)